Literature DB >> 23114623

Resveratrol attenuates L-DOPA-induced hydrogen peroxide toxicity in neuronal cells.

Carina S Peritore1, Angela Ho, Bryan K Yamamoto, Scott E Schaus.   

Abstract

A variety of polyphenol antioxidant compounds derived from natural products have demonstrated neuroprotective activity against neuronal cell death. The objective of this study was to investigate the effect of resveratrol (RESV) and bioflavonoids in attenuating hydrogen peroxide (H(2)O(2))-induced oxidative stress in neuronal cells. H2O2 levels were increased by the addition of L-3,4-dihydroxyphenylalanine (L-DOPA) to cultured dopaminergic SKNSH cells. H(2)O(2) was monitored by peroxyfluor-1, a selective H(2)O(2) optical probe. To examine the neuroprotective effects of RESV and bioflavonoids against L-DOPA, we cotreated RESV, quercetin, or (-) epigallocatechin gallate with L-DOPA and monitored for H(2)O(2) levels. The combination of RESV and L-DOPA was 50% more effective at reducing H(2)O(2) levels than the combination of quercetin or epigallocatechin gallate with L-DOPA. However, the combination of each antioxidant with L-DOPA was effective at preserving cell viability.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23114623      PMCID: PMC5705237          DOI: 10.1097/WNR.0b013e32835a4ea4

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  24 in total

1.  Telomerase and neuronal marker status of differentiated NT2 and SK-N-SH human neuronal cells and primary human neurons.

Authors:  Pooja Jain; Maria A Cerone; Andréa C Leblanc; Chantal Autexier
Journal:  J Neurosci Res       Date:  2007-01       Impact factor: 4.164

2.  Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones.

Authors:  J L Biedler; S Roffler-Tarlov; M Schachner; L S Freedman
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

Review 3.  Catecholamine metabolism: basic aspects and clinical significance.

Authors:  I J Kopin
Journal:  Pharmacol Rev       Date:  1985-12       Impact factor: 25.468

4.  Catecholamines in neuroblastoma cells from human bone marrow, tissue culture, and murine C-1300 tumor.

Authors:  L Helson; J L Biedler
Journal:  Cancer       Date:  1973-05       Impact factor: 6.860

Review 5.  L-DOPA: a scapegoat for accelerated neurodegeneration in Parkinson's disease?

Authors:  Janusz Lipski; Robert Nistico; Nicola Berretta; Ezia Guatteo; Giorgio Bernardi; Nicola B Mercuri
Journal:  Prog Neurobiol       Date:  2011-06-24       Impact factor: 11.685

6.  Toxic and protective effects of L-dopa on mesencephalic cell cultures.

Authors:  C Mytilineou; S K Han; G Cohen
Journal:  J Neurochem       Date:  1993-10       Impact factor: 5.372

Review 7.  Roles of vitamins E and C on neurodegenerative diseases and cognitive performance.

Authors:  Antonio Martin; Kuresh Youdim; Aleksandra Szprengiel; Barbara Shukitt-Hale; James Joseph
Journal:  Nutr Rev       Date:  2002-10       Impact factor: 7.110

8.  L-dopa increases nigral production of hydroxyl radicals in vivo: potential L-dopa toxicity?

Authors:  T S Smith; W D Parker; J P Bennett
Journal:  Neuroreport       Date:  1994-04-14       Impact factor: 1.837

9.  Green tea epigallocatechin 3-gallate accumulates in mitochondria and displays a selective antiapoptotic effect against inducers of mitochondrial oxidative stress in neurons.

Authors:  Emily K Schroeder; Natalie A Kelsey; Jeanne Doyle; Elise Breed; Ron J Bouchard; F Alexandra Loucks; R Alex Harbison; Daniel A Linseman
Journal:  Antioxid Redox Signal       Date:  2009-03       Impact factor: 8.401

Review 10.  Nutraceutical antioxidants as novel neuroprotective agents.

Authors:  Natalie A Kelsey; Heather M Wilkins; Daniel A Linseman
Journal:  Molecules       Date:  2010-11-03       Impact factor: 4.411

View more
  5 in total

1.  L-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells.

Authors:  Branden J Stansley; Bryan K Yamamoto
Journal:  Neuropharmacology       Date:  2012-11-27       Impact factor: 5.250

2.  1,25-dyhydroxyvitamin D3 attenuates L-DOPA-induced neurotoxicity in neural stem cells.

Authors:  Wooyoung Jang; Hyun-Hee Park; Kyu-Yong Lee; Young Joo Lee; Hee-Tae Kim; Seong-Ho Koh
Journal:  Mol Neurobiol       Date:  2014-08-08       Impact factor: 5.590

Review 3.  Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders.

Authors:  David S Goldstein; Irwin J Kopin; Yehonatan Sharabi
Journal:  Pharmacol Ther       Date:  2014-06-16       Impact factor: 12.310

4.  Dopamine D2 receptor and β-arrestin 2 mediate Amyloid-β elevation induced by anti-parkinson's disease drugs, levodopa and piribedil, in neuronal cells.

Authors:  Jing Lu; Xiaohang Li; Qinying Wang; Gang Pei
Journal:  PLoS One       Date:  2017-03-02       Impact factor: 3.240

5.  Resveratrol protects DAergic PC12 cells from high glucose-induced oxidative stress and apoptosis: effect on p53 and GRP75 localization.

Authors:  Justine Renaud; Julie Bournival; Ximena Zottig; Maria-Grazia Martinoli
Journal:  Neurotox Res       Date:  2013-11-12       Impact factor: 3.911

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.